1910 and Abalone Bio are both classified in the Healthcare sector on Brel. Both companies are based in United States. 1910 focuses on multimodal AI Platform for Modality Agnostic Drug Discovery™, while Abalone Bio focuses on we create activating antibodies to treat diseases others can’t..
1910 is a Healthcare AI company on Brel, based in United States, founded in 2019. Verified focus: Multimodal AI Platform for Modality Agnostic Drug Discovery™.
Abalone Bio is a Healthcare AI company on Brel, based in United States, founded in 2020. Verified focus: We create activating antibodies to treat diseases others can’t.
AI in Healthcare · United States
Compare intelligence acrossSectorCapabilitiesIndustries served
Key differences
Sector
Same — Healthcare
Country
Same — United States
Founded
19102019
Abalone Bio2020
Stage
1910Growth
Abalone BioEarly
Status
Same — Active
Product summary
1910Multimodal AI Platform for Modality Agnostic Drug Discovery™
Abalone BioWe create activating antibodies to treat diseases others can’t.
Capabilities
1910Multimodal AI Platform for Modality Agnostic Drug Discovery™
Abalone BioWe create activating antibodies to treat diseases others can’t.
Industries served
Same — AI in Healthcare
Verification
Same — verified
Where they overlap
Sectors
Healthcare
Industries
AI in Healthcare
Sectors
1910Abalone Bio
Industries
Where they differ
Dimension1910Abalone Bio
CapabilitiesMultimodal AI Platform for Modality Agnostic Drug Discovery™We create activating antibodies to treat diseases others can’t.